Business Wire

New Century AIM VCT Plc UK Regulatory Announcement: Annual Financial Report

LONDON–(BUSINESS WIRE)– 

New Century AIM VCT plc

Audited Report and Accounts for the year to 28th February 2021

Company number: 05352611

Financial Summary

1

Chairman’s Statement

2

Details of Directors

3

Management and Administration

4

Directors

5

Strategic Report

6

Investment Portfolio

8

Top Ten Investments

11

Directors’ Report

12

Directors’ Remuneration Report

16

Corporate Governance

18

Independent Auditor’s Report

22

Statement of Comprehensive Income

29

Balance Sheet

30

Statement of Changes in Equity

31

Cash Flow Statement

32

Notes to the Financial Statements

33 – 44

Shareholder Information

45

Financial Summary

 

 

 

Year ended

28 February

2021

Year ended

29 February

2020

 

Revenue return per share (pence) for the year

(0.47)

0.19

 

Total return per share (pence) for the year

38.49

0.66

 

Interim dividend paid per share (pence)

1.50

0.00

 

Proposed final dividend per share (pence)

6.50

0.00

 

Net asset value per share (pence)

102.96

65.97

 

Cumulative value of shareholder investment (net asset value plus cumulative dividends per share) (pence)

131.78

93.29

 

Shareholders’ funds (£’000)

8,094

5,186

Chairman’s Statement

It is pleasing to report that following a very difficult period for the Market in March 2020, your fund regained all the declines in its net asset value (NAV) incurred during the early part of the year, and considerably outperformed its benchmark for the twelve months to 28 February 2021.

The NAV of your fund increased by 56.07% to 102.96p (when measured using bid-prices), compared to the FTSE AIM Allshare index which gained 38.13% over the same period. The net asset value plus cumulative dividends rose from 93.29p to 131.78p per share, being an increase of 41.26%.

It is also pleasing to note the further progress since the year end, and that the NAV of 120.02p per share reported for 28 May 2021 (based on mid-prices) is 14.33% higher than that reported, using the same measurement basis, at the 28 February 2021.

We appreciate income is important to our shareholders and the Board is therefore proposing that we pay a final dividend of 6.5p per share in respect of the year ended 28 February 2021. When this is added to the 1.5p interim dividend already paid, this results in a total dividend for the year of 8.0p and represents a yield of 8% based on the fund’s offer price of 100p on 28 May 2021.

The fund has made fifteen further qualifying investments in the period and we are pleased with their progress. We made twelve sales where we either exited or top-sliced a holding.

We are mindful that we could see further volatility this year as the economy has an initial boost from the reopening of lockdown measures, but this could be followed by some businesses starting to experience difficulties in the months ahead as Government support subsides, and the possibility of inflation may also raise its head. That said, the current year has started off positively as commented earlier and we have a wide spread of established companies across a variety of sectors within the fund, and we therefore look forward to the year ahead with optimism.

Finally, the Directors have a duty every five years to ask the shareholders of the Company if they wish the fund to carry on. Therefore, amongst the resolutions shareholders are being asked to vote on at the forthcoming AGM, there is an Ordinary Resolution offering shareholders the opportunity to vote on this particular matter.

Geoffrey Gamble

24 June 2021

Details of Directors

Michael Barnard (Aged 70)

Michael has been employed in stockbroking since 1971. In 1974 he became a Member of the Stock Exchange. During his career his duties have spanned investment advising, investment research, dealing and company management. In 1988 he started his own stockbroking company, MD Barnard & Company Limited which he subsequently sold on 30 November 2017.

Geoffrey Gamble (Aged 62)

Geoffrey started his career with National Westminster Bank plc. He joined Publishing Holdings plc in 1984 and became a director in 1986. He took part in an MBO in 1988, backed by Schroder Ventures (now Permira) to form Charterhouse Communications Group Limited and was instrumental in the satisfactory venture capital exit from that company and its flotation on AIM in 1996. He became managing director of Charterhouse Communications plc in 1999.

Peter William Riley (Aged 76)

Peter qualified as a solicitor in 1969. He retired from practice in 2018.

Ian Cameron-Mowat (Aged 70)

Ian has a BSc 1st degree in electronics and was involved in the early development of computers at Burroughs Machines. He is currently a consultant radiologist to a NHS Trust.

Simon Like (Aged 51)

Simon started his career working for Midland Bank, which later became HSBC plc, and has been employed in stockbroking since 2001. Since then Simon has been managing client money and is one of the senior fund managers at Oberon Investments Limited.

Management and Administration

Registered Office & Registered Number

 

 

4th Floor,

50 Mark Lane

London

EC3R 7QR

Company Number: 05352611

 

 

Company Secretary

 

 

 

Tricor Secretaries Limited

4th Floor,

50 Mark Lane

London

EC3R 7QR

 

 

Registrar

 

 

 

Neville Registrars Limited

Neville House

Steelpark Road

Halesowen

B62 8HD

 

 

Solicitors

 

 

 

Dundas & Wilson

5th Floor, Northwest Wing

Bush House

Aldwych

London

WC2B 4EZ

 

 

Investment Manager and Broker

 

 

 

Oberon Investments Limited

1st Floor

12 Hornsby Square

Southfields Business Park

Basildon

Essex

SS15 6SD

 

 

Auditor

 

 

 

UHY Hacker Young LLP

Quadrant House

4 Thomas More Square

London

E1W 1YW

 

 

Directors

Geoffrey Gamble (Chairman)

Michael David Barnard

Peter William Riley

Ian Cameron-Mowat

Simon Like

 

All directors are non-executive.

 

Audit Committee:

 

Geoffrey Gamble (Chairman)

Peter William Riley

Ian Cameron-Mowat

Strategic Report

Activities and status

The principal activity of the Company during the year was the making of long-term equity and loan investments in UK Listed, AIM traded and unquoted companies in the United Kingdom. The Company has been listed on the London Stock Exchange since 25 March 2005 and has been granted approval by Her Majesty’s Customs & Revenue as a Venture Capital Trust. The Chairman’s Statement on page 2 and the Investment Manager’s Review below give a review of developments during the year and of future prospects.

The directors consider that the Company was not at any time up to the date of this report a close company within the meaning of Section 414 of the Act.

Investment Manager’s Review

The FTSE AIM All Share index had a good performance throughout the year, although it started negatively with the index falling in early March 2020 as the outbreak of COVID19 started to spread across the world. Since then, however, the trend of the index has been generally up. Many investors started to look at the year as an exceptional year in terms of earnings’ declines, and looked more carefully at the position of companies’ finances and in particular their financial strength to trade successfully once the economy opened up again. We had a couple of false dawns when it was hoped that some sort of return to normality would occur only to be met with a second and third wave of the virus. It is now looking much brighter as the UK is undertaking what looks to be a successful mass vaccination programme which will hopefully allow businesses to open fully and unrestricted from 19 July 2021.

During the year to 28th February 2021 the net asset value (NAV) of your fund increased by 56.07% to 102.96p, compared to the FSTE AIM All Share index which gained 38.13% over the same period. The net asset value of the fund plus cumulative dividends per share increased by 41.26%.

The fund made fifteen qualifying investments in the period, investing in Actual Experience plc, Abingdon Health plc, AFC Energy plc, Deepmatter plc, Destiny Pharma plc, Eden Research plc, ECSC Group plc, Falanx Group plc, Feedback plc, Fusion Antibodies PLC, Gfinity plc, Intelligent Ultrasound Group plc, Mirriad Advertising plc, MyHealthCheck plc and Synairgen plc.

We made twelve sales during the year where we either exited or top-sliced a holding.

The current year has started well, with the NAV of the fund climbing to 120.02p by the end of May 2021 as there has been more optimism by both investors and companies over the prospects for the year ahead. Your fund has a wide spread of investments across a variety of many sectors and we believe that this diversification will help the Company weather any volatility that may occur in the period ahead. These are unprecedented times and with so many countries trying to contain the virus it is impressive how quickly numerous vaccines have been created to help fight the pandemic. We have also begun to see that some companies have recommenced dividend payments again, as they start to become more confident about their future cash flows and prospects. We are also continuing to see many companies using the public markets to raise cash to support their balance sheets and provide growth capital. This in itself can create new opportunities for your fund as it will give us the chance to invest in exciting new prospects.

I am proud about the way the fund has performed this year and I look forward to the year ahead with cautious optimism.

Investment Objective

New Century AIM VCT PLC is a Venture Capital Trust (“VCT”) established under the legislation introduced in the Finance Act 1995. The Company’s principal objectives as set out in the prospectus are to achieve long term capital growth through investment in a diversified portfolio of Qualifying Companies primarily quoted on AIM.

Principal risks and uncertainties

The Company invests its funds primarily in companies traded on AIM, which entail a higher degree of risk than investments in large listed companies. The main risk, therefore, arising from the Company’s activities is market price risk, representing the uncertain realisable values of the Company’s investments. Please refer to the Corporate Governance report on page 18 which provides evidence of the robust review the directors have performed to assess these risks, and also note 22 to these accounts which gives a detailed review of the Company’s risk management.

Environmental matters

Discussion in respect of environmental matters is not considered relevant or material to an understanding of the performance of the Company. The Company does not consider that Greenhouse Gas Emissions disclosure is relevant to the Company on the grounds of immateriality due to its not having its own premises or employees.

Key performance indicators

The financial key performance indicators are set out in the financial summary on page 1.

Viability Statement

In accordance with provision 1 of The UK Corporate Governance Code 2018 the directors have assessed the prospects of the Company over a longer period than the 12 months required by the “Going Concern” provision.

The Board regularly considers the Company’s strategy, including investor demand for the Company’s shares, and a three year period is therefore considered to be an appropriate and reasonable time horizon.

The Board has carried out a robust assessment of the principal risks facing the Company and its current position, including those which may adversely impact its business model, future performance, solvency or liquidity. The principal risks faced by the Company and the procedures in place to monitor and mitigate them are set out in note 22.

The Board has also considered the Company’s cash flow projections and found these to be realistic and reasonable.

Based on the above assessment the Board confirms that it has a reasonable expectation that the Company will be able to continue in operation and meet its liabilities as they fall due over the three year period to 28 February 2024.

Geoffrey Gamble

Chairman

24 June 2021

Investment Portfolio

Security

Original
Cost

Valuation at
28 Feb’21

Cost

Valuation

 

£

£

%

%

 

 

 

 

 

Qualifying Investments

6,753,744

7,794,913

91.77

95.91

Non-qualifying Investments

482,628

209,312

6.56

2.58

 

7,236,372

8,004,225

98.33

98.49

Uninvested funds

123,089

123,089

1.67

1.51

 

7,359,461

8,127,314

100.00

100.00

 

Qualifying Investments

 

 

 

 

AIM quoted

 

 

 

 

Abingdon Health plc

35,218

32,777

0.48

0.40

Access Intelligence plc

10,053

29,000

0.14

0.36

Actual Experience plc

63,174

70,638

0.86

0.87

AFC Energy

50,254

168,125

0.68

2.07

Angle plc

125,880

157,237

1.71

1.93

Anglo African Oil & Gas plc

45,229

675

0.61

0.01

Audioboom Group plc

178,406

308,880

2.42

3.80

Bango plc

7,563

36,225

0.10

0.45

Belvoir Lettings plc

23,320

32,800

0.32

0.40

Bigblu Broadband plc

239,452

391,788

3.25

4.82

Bilby plc

156,673

91,381

2.13

1.12

Blackbird plc

97,991

461,175

1.33

5.67

Bould Opportunities plc

35,179

0

0.48

0.00

Brighton Pier Group plc

50,253

11,031

0.68

0.14

C4X Discovery Holding plc

65,329

157,733

0.89

1.94

Cloudbuy plc

58,483

228

0.79

0.00

Cloudcall Group plc

20,230

30,100

0.27

0.37

Coral Products plc

118,095

83,333

1.60

1.03

Creo Medical Group plc

30,053

86,159

0.41

1.06

Cyanconnode Holdings plc

376,755

46,726

5.12

0.57

DCD Media plc

562,800

1,700

7.65

0.02

Deepmatter Group plc

49,754

81,840

0.68

1.01

Deepverge plc

121,304

93,840

1.65

1.15

Destiny Pharma plc

50,254

86,923

0.68

1.07

Diaceutics plc

10,314

17,415

0.14

0.21

DP Poland plc

20,113

11,939

0.27

0.15

Ecsc Group plc

20,104

23,637

0.27

0.29

Eden Research plc

30,152

97,000

0.41

1.19

Escape Hunt plc

31,006

5,530

0.42

0.07

Falanx Group Ltd

150,964

97,653

2.05

1.20

Faron Pharmaceuticals Ltd

25,128

32,650

0.34

0.40

Feedback plc

100,508

117,629

1.37

1.45

Fusion Antibodies plc

12,064

15,534

0.16

0.19

Gear4Music Holdings plc

27,121

150,070

0.37

1.85

Gfinity plc

116,218

153,829

1.58

1.89

Hunters Property plc

251,256

325,000

3.41

4.00

IDE Group Holdings plc

52,763

1,396

0.72

0.02

 

 

 

 

 

 

 

 

 

 

Security

Original
Cost

Valuation at
28 Feb’21

Cost

Valuation

 

£

£

%

%

 

 

 

 

 

Ideagen plc

28,430

227,117

0.39

2.79

Immotion Group plc

130,661

74,678

1.78

0.92

I-Nexus Global plc

70,353

5,494

0.96

0.07

Inspired Energy plc

51,370

259,133

0.70

3.19

Intelligent Ultrasound Group plc

170,848

149,908

2.32

1.84

K3 Business Technology Group plc

90,360

178,821

1.23

2.20

Keywords Studios plc

5,563

113,040

0.08

1.39

Lightwaverf plc

45,233

3,177

0.61

0.04

Location Sciences Group plc

132,946

29,161

1.81

0.36

M.Winkworth plc

64,320

108,800

0.87

1.34

Marechale Capital plc

133,828

65,323

1.82

0.80

Maxcyte Inc

25,128

348,212

0.34

4.28

Microsaic Systems plc

164,417

7,792

2.23

0.10

Mirriad Advertising plc

30,154

38,850

0.41

0.48

Myhealthchecked plc

200,550

366,282

2.73

4.51

N4 Pharma plc

60,304

54,600

0.82

0.67

Open Orphan plc

115,581

137,470

1.57

1.69

Pelatro plc

25,128

14,400

0.34

0.18

PHSC plc

182,910

45,500

2.49

0.56

Polarean Imaaging plc

30,154

129,600

0.41

1.59

Property Franchise Group plc

100,503

190,000

1.37

2.34

Quixant plc

6,935

17,700

0.09

0.22

Rosslyn Data plc

27,037

5,339

0.37

0.07

Scancell Holdings plc

130,618

217,361

1.77

2.67

Scholium Group plc

50,253

15,500

0.68

0.19

SEEEN plc

150,754

130,000

2.05

1.60

Solid State plc

40,134

125,070

0.55

1.54

SRT Marine Systems plc

27,139

52,500

0.37

0.65

Sysgroup plc

99,178

65,780

1.35

0.81

Tekcapital plc

77,499

52,200

1.05

0.64

Touchstar plc

281,400

88,750

3.82

1.09

TP Group plc

109,278

45,157

1.49

0.56

Tristel plc

38,409

578,592

0.52

7.12

ULS Technology plc

48,241

101,160

0.66

1.24

Verici Dx plc

35,178

119,875

0.48

1.47

Vianet Group plc

40,175

24,050

0.55

0.30

Total AIM quoted qualifying investments

6,537,622

7,794,913

88.83

95.91

 

Unlisted qualifying Investments

 

 

 

 

Invocas Group plc

100,400

0

1.36

0.00

Optare plc

45,027

0

0.61

0.00

Outsourcery plc

50,752

0

0.70

0.00

Syqic plc

19,943

0

0.27

0.00

Total Unlisted qualifying investments

216,122

0

2.94

0.00

 

 

 

 

 

Total Qualifying Investments

6,753,744

7,794,913

91.77

95.91

 

 

 

 

 

Security

Original

Cost

Valuation at

28 Feb’21

Cost

Valuation

 

£

£

%

%

Non-qualifying Investments

 

 

 

 

AIM quoted

 

 

 

 

Audioboom Group plc

1,163

429

0.02

0.01

Bango plc

291

414

0.00

0.01

Cyanconnode Holdings plc

131

8

0.00

0.00

Driver Group plc

8,992

5,000

0.12

0.06

Gateley Holdings plc

14,627

26,400

0.20

0.31

IDE Group Holdings plc

218

2

0.00

0.00

K3 Business Technology Grp plc

131

179

0.00

0.00

Rotala plc

60,795

51,644

0.83

0.64

Tristel plc

60

588

0.00

0.01

 

 

 

 

 

 

86,408

84,664

1.17

1.04

UK Listed

 

 

 

 

Aviva plc

22,268

18,090

0.30

0.22

Centrica plc

10,074

1,582

0.14

0.02

Imperial Brands plc

23,764

13,325

0.32

0.16

Investec plc

202,821

70,975

2.77

0.88

Twentyfour Income Fund Ltd

9,852

9,360

0.13

0.12

Vodafone Group plc

20,590

11,316

0.28

0.14

 

 

 

 

 

 

289,369

124,648

3.93

1.54

Unlisted Investments

 

 

 

 

China Food Company plc

65,969

0

0.91

0.00

Gable Holdings Inc

12,112

0

0.16

0.00

Mar City plc

10,053

0

0.14

0.00

Sorbic International plc

18,717

0

0.25

0.00

 

 

 

 

 

 

106,851

0

1.46

0.00

 

 

 

 

 

Total non-qualifying investments

482,628

209,312

6.56

2.58

 

 

 

 

 

Security

Original

Cost

Valuation at

28 Feb’21

Cost

Valuation

 

£

£

%

%

 

 

 

 

 

Tristel plc

38,469

579,180

0.52%

7.13%

Blackbird plc

97,991

461,175

1.33%

5.67%

Bigblu Broadband plc

239,452

391,788

3.25%

4.82%

Myhealthchecked plc

200,550

366,282

2.73%

4.51%

Maxcyte Inc Com

25,128

348,212

0.34%

4.28%

Hunters Property plc

251,256

325,000

3.41%

4.00%

Audioboom Group plc

179,569

309,309

2.44%

3.81%

Inspired Energy plc

51,370

259,133

0.70%

3.19%

Ideagen plc

28,430

227,117

0.39%

2.79%

Scancell Holdings plc

130,618

217,361

1.77%

2.67%

The investments tabulated above are expressed as a percentage of the Company’s investment portfolio including uninvested cash.

Directors’ Report

The directors present their report and the audited financial statements for the year to 28 February 2021.

Corporate Governance

The Corporate Governance report on pages 18 to 21 forms part of the directors’ report.

Results and dividends paid

 

Year to

28 February 2021

Year to
29 February 2020

 

Revenue

Capital

Revenue

Capital

 

£’000

£’000

£’000

£’000

 

Return on ordinary activities after taxation

(36)

3,063

15

38

 

 

 

 

 

Appropriated as follows:

 

 

 

 

 

 

 

 

 

Interim dividend paid in respect of current period

 

 

 

 

Revenue – Nil (Nil) per share

 

 

 

 

 

Capital – 1.50p (Nil) per share

(118)

 

 

 

 

 

Final dividend paid in respect of prior period

 

 

 

 

Revenue – Nil (0.186p) per share

(15)

 

 

 

 

 

Capital – Nil (3.314p) per share

(260)

 

 

 

 

 

 

 

 

 

 

Transfers to reserves

(36)

2,945

(222)

The directors propose to declare a final dividend for the year ended 28 February 2021 of 6.5p per share which, when added to the interim dividend of 1.5p per share (already paid on 4 December 2020), gives a total dividend for the year of 8.0p per share.

There was no dividend declared for the year ended 29 February 2020.

Directors

The directors of the Company are required to notify their interests under Disclosure and Transparency Rule 3.12R. The membership of the Board and their beneficial interests in the ordinary shares of the Company are set out below:

 

Year ended

28 February 2021

Year ended

29 February 2020

 

 

Michael Barnard

Geoffrey Gamble

Peter William Riley

Ian Cameron-Mowat

 

2,159,035

97,125

59,185

110,904

 

2,159,035

61,732

59,185

110,904

Simon Like

8,800

8,800

 

 

 

All of the directors’ share interests shown above are held beneficially. There have been no changes in the directors’ share interests between 28 February 2021 and the date of this report.

Brief biographical notes on the directors are given on page 3. The director, retiring in accordance with the Company’s Articles of Association, is Geoffrey Gamble, who being eligible will offer himself for re-election at the forthcoming Annual General Meeting (AGM). The directors believe his experience in small companies is a great benefit to the Board and recommend his re-election.

None of the directors has a contract of service with the Company and, except as mentioned below under the heading “Management”, there were no contracts that subsisted during the year in which a director was materially interested and which was significant in relation to the Company’s business.

Management

MD Barnard & Co. Ltd (now called Oberon Investments Limited) has acted as investment manager to the Company since inception. The principal terms of the Investment Management Agreement are set out in Note 6 to the Financial Statements.

Substantial shareholdings

As at 28 February 2021 the Company had been notified of the following shareholdings representing 3 per cent or more of the Company’s issued share capital during the year under review or at the date of this report:

 

Number

Percentage

of share capital

 

Michael Barnard

Geoffrey Williams

Nigel Shanks

David Trotman

John Brice

Roger Carey

 

2,159,035

391,570

364,820

324,000

290,988

241,048

 

27.47%

4.98%

4.64%

4.12%

3.70%

3.07%

 

Acquisition of own shares

During the year the Company did not re-purchase any of its own shares.

Structure, rights and restrictions concerning the Company’s share capital

Throughout the Company’s financial year there were 7,860,937 ordinary shares in issue. No shares were issued or bought back during the year. The rights and obligations attached to the Company’s ordinary shares are set out in the Company’s Articles of Association, copies of which can be obtained from Companies House. The Company has only one class of ordinary share and each share has attached to it full voting rights, dividends and capital distribution rights (including on a winding up) and do not confer any rights of redemption.

Ordinary shareholders also have the right to receive copies of the Company’s report and accounts, to attend and speak at general meetings and to appoint proxies.

There is one shareholder, Michael Barnard, who is a major shareholder in the Company with a 27.47% shareholding. He is also a director of the Company and taken together he is considered to have a significant influence over the Company. Other than Michael Barnard, there are no other shareholders who have a significant direct or indirect shareholding in the Company.

In accordance with Schedule 7 of the Large and Medium Size Companies and Groups (Accounts and Reports) Regulations 2008, as amended, the directors disclose the following information:

  • The Company’s capital structure and voting rights are summarised above, and there are no restrictions on voting rights nor any agreement between holders of securities that result in restrictions on the transfer of securities or on voting rights;
  • There exist no securities carrying special rights with regard to the control of the Company;
  • The rules concerning the appointment and replacement of directors, amendment of the Articles of Association and powers to issue or buy back of the Company’s shares are contained in the Articles of Association of the Company and the Companies Act 2006;
  • The Company does not have an employee share scheme;
  • There are no agreements to which the Company is party that may affect its control following a takeover bid; and
  • There are no agreements between the Company and its directors providing for compensation for loss of office that may occur following a takeover bid or for any other reason.

Appointment of Directors

The directors are subject to re-election by rotation, with one of the directors being re-elected annually at the AGM.

Creditor payment policy

The Company’s payment policy is to agree terms of payment before business is transacted and to settle accounts in accordance with those terms. The Company’s principal expenses such as investment management fees and administration fees are paid quarterly in arrears in accordance with the respective agreements. Accordingly the Company had no material trade creditors at the year end.

Streamlined Energy and Carbon Reporting

There are new reporting requirements which make it mandatory for companies to report the amount of energy they use during their financial year. The Company’s energy usage is below the de minimis level of 40,000kWh.

Post balance sheet events

Details of the post balance sheet event are set out in note 27.

Contacts

NEW CENTURY AIM VCT PLC

Read full story here

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button